The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
Introduction. Glioblastoma is the most common primary malignant glial tumor of the brain in adult patients. Median overall survival for this pathology varies between 3 and 12 months, and only 5 % of patients live for more than 5 years. Current treatment methods allow to slightly increase lifespan of...
Saved in:
Main Authors: | A. V. Kaminskiy, N. P. Zverev, A. A. Lyakhovets, D. R. Naskhletashvili, M. A. Gairyan, A. A. Isaev, D. N. Khmelkova, I. L. Plaksa |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2023-06-01
|
Series: | Опухоли головы и шеи |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/866 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic potential of curcumin for the treatment of glioblastoma multiforme
by: T. I. Kushnir, et al.
Published: (2020-03-01) -
Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01) -
Severe Unilateral Alopecia in a Long-Term Surviving Male Adolescent Glioblastoma Multiforme Patient
by: Xiong L, et al.
Published: (2025-06-01) -
The effect of hypoxia on the secretome of human glioblastoma multiforme cells
by: T. I. Kushnir, et al.
Published: (2021-05-01) -
The Effect of Adjuvant Chemoradiotherapy Initiation Time on Prognosis in Glioblastoma Multiforme
by: Engin Eren Kavak, et al.
Published: (2025-03-01)